Patheon 4Q08 (ended 10/08) 4Q Revenues: $172 million (+6%) 4Q Earnings: $37 million (loss of $7.5 million in 4Q07) FY Revenues: $717 million (+13%) FY Loss: $1.4 million (loss of $94.6 million in FY07) Comments: Commercial manufacturing revenues increased 11% for the year to $577.7 million, reflecting growth in European, Canadian and Puerto Rican operations. Pharmaceutical Development Services revenues grew 20% to $139.5 million. After the fiscal year ended, Patheon chose to shut ...